Salvage treatment with etoposide (VP‐16), ifosfamide and cytarabine (Ara‐C) for patients with recurrent primary central nervous system lymphoma
- 26 March 2003
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 70 (4) , 219-224
- https://doi.org/10.1034/j.1600-0609.2003.00045.x
Abstract
Background: Survival of patients with primary central nervous system lymphoma (PCNSL) has improved with methotrexate‐based combination regimens and radiotherapy (RT). However, the prognosi...Keywords
This publication has 24 references indexed in Scilit:
- A multicenter study of treatment of primary CNS lymphomaNeurology, 2002
- First-line therapy with temozolomide induces regression of primary CNS lymphomaNeurology, 2002
- Importance of Radiotherapy in the Outcome of Patients With Primary CNS Lymphoma: An Analysis of the CHOD/BVAM Regimen Followed by Two Different Radiotherapy TreatmentsJournal of Clinical Oncology, 2002
- Therapeutic management of refractory or relapsed primary central nervous system lymphomasAnnals of Hematology, 2001
- CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular LymphomaJournal of Clinical Oncology, 2001
- Graft-Versus-Lymphoma Effect after Allogeneic Peripheral Blood Stem Cell Transplantation for Primary Central Nervous System LymphomaLeukemia & Lymphoma, 1999
- The pharmacokinetics of cytosine arabinoside in the plasma and cerebrospinal fluid during conventional and high-dose therapyMedical and Pediatric Oncology, 1982
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataPublished by JSTOR ,1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958